BACKGROUND/MOTIVATION FOR THE STUDY {#sec1}
===================================

Unaccustomed strenuous exercise involving eccentric muscle contractions (i.e., when the muscle is active while being forcibly lengthened) induces ultrastructural muscle damage. However, the changes in muscle damage-related biomarkers, e.g., loss of strength and delayed-onset muscle soreness, differ considerably between people ([@B1]).

Tendon and the extracellular matrix (ECM), which surrounds the contractile elements of the muscle, are composed of different types of collagen. These influence the mechanical properties of the muscle-tendon unit (MTU), ultimately influencing the transmission of force from the muscle to the bone. The ECM enables muscle force to be transmitted both longitudinally and laterally to the tendon, and, during eccentric contractions, external force can be transmitted laterally to the sarcomeres, causing MTU damage ([@B5]).

Single nucleotide polymorphisms (SNPs) of collagen genes have been associated with MTU mechanical properties ([@B4]) and injury risk ([@B2]), possibly by affecting RNA stability and hence collagen abundance. Furthermore, resistance exercise increases collagen gene expression ([@B3]), but no study has investigated whether SNPs of collagen-encoding genes are associated with the response to exercise-induced muscle damage (EIMD). Therefore, we aimed to investigate if intron SNPs within the *COL1A1* (*T/C*, [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492); G/T [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012)) and in *COL5A1* (T/C, [rs12722](https://www.ncbi.nlm.nih.gov/snp/12722)) genes, and a missense SNP within the *COL2A1* (G/A, [rs2070739](https://www.ncbi.nlm.nih.gov/snp/2070739)) gene, which encode the alpha-1 chain of type I, V and II collagens, respectively, were associated with the skeletal muscle response to EIMD in untrained young men and women.

PHENOTYPE {#sec2}
=========

Following familiarization, all participants performed the following assessments before, immediately after, and 48 h after, 12 sets of 10 maximal eccentric unilateral knee extension contractions (EIMD protocol): *1*) maximum voluntary isometric (80° knee flexion) and *2*) isokinetic (60°/s) knee-extension contraction (MVC) torque (Humac Norm; CSI, Stoughton, MA, and Biodex Multi-Joint System 3 Pro, Shirley, NY) normalized to body mass; and *3*) muscle soreness \[visual analog scale (0--10 cm; 0 cm = no soreness; 10 cm = maximal soreness) in conjunction with a three-repetition squat\]. A venous blood sample was drawn from an antecubital vein (1 × 10 ml; BD EDTA vacutainer) for genotypic analysis.

 {#sec2-1}

### Cohort details. {#sec2-1-1}

Sixty-five untrained, healthy (identified by physical activity and health questionnaires) female (*n* = 39) and male (*n* = 26) Caucasians (mean ± SD; age = 22.5 ± 4.0 yr; height = 1.71 ± 0.09 m; body mass = 70.9 ± 14.4 kg) were recruited in this population cohort study. All recruits gave written, informed consent to participate in the study, which was approved by the Liverpool John Moores University Ethics Committee in accordance with the Declaration of Helsinki. Inclusion criteria included age between 18 and 35 yr, and potential participants were excluded if they *1*) had performed leg resistance training within the last 6 mo, and *2*) suffered a muscle-tendon injury in the last 12 mo and/or bone fracture in the lower limbs. Participants were instructed to maintain their normal routine, to refrain from drinking alcohol, and to avoid any exercise 48 h before each testing session and throughout the study.

### Type of study. {#sec2-1-2}

Purification of DNA was performed using QIAamp DNA Blood Kit (Qiagen, Crawley, UK) and was prepared according to manufacturer protocols for this candidate SNP study. Each participant was genotyped for *COL1A1* (T \> C, [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492); G\>T [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012)), *COL2A1* (G\>A, [rs2070739](https://www.ncbi.nlm.nih.gov/snp/2070739)), and *COL5A1* (T \> C, [rs12722](https://www.ncbi.nlm.nih.gov/snp/12722)) SNPs via real-time polymerase chain reaction (PCR) with a Rotor-Gene Q (Rotor-Disk) Instrument (Qiagen). The 10 µl reaction volume included 5 µl Genotyping Master Mix (Applied Biosystems, Foster City, CA), 0.5 µl genotyping assay (Applied Biosystems), 3.5 µl nuclease-free H~2~O (Qiagen), and 1 µl DNA. For control wells, 1 µl nuclease-free H~2~O replaced the DNA template. Reactions were incubated in a 72-well optical plate at 92°C for 15 s (denaturation), followed by annealing and extension at 60°C for 1 min (60 cycles). Each sample was run in duplicate, and there was 100% agreement between samples from the same participant. Genotype calls were performed with Rotor-Gene Q Software 2.3.1 (Qiagen).

### Details of the SNP(s) studied. {#sec2-1-3}

The *COL1A1* [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492) and [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012) SNPs are located on chromosome 17 at position 50,185,660 and 50,200,388, respectively. The position of the *COL2A1* [rs2070739](https://www.ncbi.nlm.nih.gov/snp/2070739) SNP is at 47,974,193 on chromosome 12, and the *COL5A1* [rs12722](https://www.ncbi.nlm.nih.gov/snp/12722) SNP is located on chromosome 9 at position 134,842,570 (dbSNP Build 151). The frequency of the effect (major) *COL1A1* [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492) T-allele is 0.54; the *COL1A1* [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012) G-allele is 0.83; the *COL2A1* [rs2070739](https://www.ncbi.nlm.nih.gov/snp/2070739) G-allele is 0.92; and the *COL5A1* [rs12722](https://www.ncbi.nlm.nih.gov/snp/12722) T-allele is 0.52. The alleles all refer to the forward DNA strand. Linkage disequilibrium (LD) calculations for the *COL1A1, COL2A1*, and *COL5A1* SNPs were carried out using the LDlink suite and data from the 1000 Genomes Project European ancestry populations (for references, see Appendix 3 in the supplemental material). (The online version of this article contains supplemental material.)

### Analysis model. {#sec2-1-4}

The violations of Hardy-Weinberg equilibrium (HWE) for each SNP were examined using χ^2^ tests. All parameters were normally distributed according to the Shapiro-Wilk test and by inspection of the Q-Q plots. Genotype associations with isometric and isokinetic knee-extension MVC torque, and muscle soreness over time were investigated via two-way mixed ANCOVAs \[within-subjects factor: time (pre-, post-, and 48 h post); between-subjects factor: genotype; covariate: sex). Recessive models were used when *n* ≤ 2 for one genotype, and false discovery rate (FDR) was performed to account for multiple testing (FDR set at \<20%; for references, see Appendix 3). All results were expressed as means ± SD. MVC data were analyzed with AcqKnowledge software 4.4 (Biopac-Systems), and statistical analyses was performed using SPSS 23 (IBM, Armonk, NY).

RESULTS {#sec3}
=======

Isometric and isokinetic MVC normalized to body mass, and muscle soreness (all *P* \< 0.001) showed a main effect of time, indicating EIMD had occurred. All genotype frequencies for the SNPs were in HWE except for *COL2A1* [rs2070739](https://www.ncbi.nlm.nih.gov/snp/2070739) (χ^2^ = 6.04, *P* = 0.014). There was a low LD for the two *COL1A1* SNPs (D\` = 0.736 and R^2^ = 0.077, *P* \< 0.001), and for the *COL1A1* and *COL2A1* SNPs with numerous *SGCA* and *TMEM106C* SNPs, respectively. There was a main effect for normalized isometric ([rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492), *P* = 0.001; [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012), *P* = 0.009) and isokinetic ([rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492), *P* = 0.001; [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012), *P* = 0.019) MVC for both *COL1A1* SNPs, with (minor) T-allele carriers ([rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012)) and (major) T-allele homozygotes ([rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492)) being weaker than their respective major (G, [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012)) and minor (C, [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492)) allele homozygote counterparts. There was a genotype × time interaction regarding muscle soreness for both *COL2A1* (*P* = 0.002) and *COL5A1* (*P* = 0.004) SNPs. *COL2A1* GG homozygotes showed attenuated soreness post-EIMD compared with A (minor) allele carriers (Supplemental Fig. S1), while *COL5A1* CC (minor allele) homozygotes showed a preferential response compared with *1*) TC genotype post-EIMD and *2*) TT genotype 48 h post-EIMD (Supplemental Fig. S2).

INTERPRETATION {#sec4}
==============

The T-alleles for both *COL1A1* SNPs were associated with lower maximum strength compared with their respective major (G, [rs1800012](https://www.ncbi.nlm.nih.gov/snp/1800012)) and minor (C, [rs2249492](https://www.ncbi.nlm.nih.gov/snp/2249492)) alleles. *COL2A1* A (minor) allele carriers and *COL5A1* T (major) allele carriers recovered more slowly from EIMD than their respective *COL2A1* G (major) allele and *COL5A1* C (minor) allele homozygote counterparts. Further work is required to *1*) validate the results in a larger independent cohort and *2*) investigate LD between these SNPs and SNPs of other genes to precisely map the causal variants and genes influencing the phenotypic outcome. However, our results suggest that these four SNPs within three collagen-encoding genes affect muscle strength and recovery following EIMD, possibly by influencing RNA stability, potentially causing dysregulation of the collagen network, thus negatively affecting the mechanical properties of the MTU.
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Appendix 3: List of consortium members and additional references (.docx 20 KB)

The G-REX (Genetics of Recovery after EXercise) Consortium members are Philipp Baumert, Bethany Adams, Josephine A. Cabot, Victoria Edwards, Kelsie O. Johnson, Mark J. Lake, Barry Drust, Claire E. Stewart, and Robert M. Erskine. For further details, see supplemental data in Appendix 3. The G-REX Consortium acknowledges the commitment and cooperation of the participants throughout the course of the study.
